(3S)-3-Amino-1-(tert-butylcarboxymethyl)-2,3,4,5-tetrahydro-1H-benzazepin-2-one is a chiral benzazepinone derivative. It features a seven-membered nitrogen-containing heterocycle (azepine) fused with a benzene ring, an amino group at the stereogenic 3-position, and a tert-butyl ester-protected acetic acid side chain on the nitrogen atom. This specific (S)-enantiomer is a key synthetic building block. This compound is primarily utilized as a crucial chiral intermediate in the pharmaceutical industry for the synthesis of active pharmaceutical ingredients (APIs). Its most notable application is in the production of vasopressin receptor antagonists, such as Tolvaptan (a V2 receptor antagonist used to treat hyponatremia) and Conivaptan. The chiral benzazepinone core and the strategically placed functional groups are essential for constructing the final drug molecule's pharmacophore. As a high-value pharmaceutical intermediate, it is typically handled under controlled conditions in research and development laboratories and manufacturing facilities. Its synthesis and purification require expertise in chiral chemistry and peptide-like bond formation.